UBS: Biotech Will Continue To Outperform In 2015 By: Benzinga via Benzinga September 08, 2015 at 13:22 PM EDT In a new report, UBS analyst Matthew Roden discusses the firm’s bullish outlook for biotech stocks. Biotech has had a strong ... Read More >> Related Stocks: Achison Inc Biomarin Pharmaceuticals Gilead Sciences Incyte Corp Prothena Corp UBS Group Ag ADR